CENTENE CORP

CNC 10-Q · Q2 2025
API behind this page

CNC Q2 2025 request

Playground key active
Request URL /api/financials?ticker=CNC&year=2025&quarter=2
waiting 0 ms 
Pick an endpoint and run the request.
curl

Income Statement

JSON CSV Excel
Income Statement
Metric Q2 2025 Q2 2024 YoY
Revenue 42,467 35,973 +18.1%
Show Product Lines breakouts
Health Care Premium 41,740 35,140 +18.8%
Health Care Premium · All Other Segments 523 399 +31.1%
Health Care Premium · Commercial 10,070 8,534 +18.0%
Health Care Premium · Medicaid 21,697 20,229 +7.3%
Health Care Premium · Medicare 9,450 5,978 +58.1%
Premium and service revenues 42,467 35,973 +18.1%
Premium and service revenues · All Other Segments 1,224 1,210 +1.2%
Premium and service revenues · Commercial 10,070 8,535 +18.0%
Premium and service revenues · Medicaid 21,723 20,250 +7.3%
Premium and service revenues · Medicare 9,450 5,978 +58.1%
Service 727 833 -12.7%
Service · All Other Segments 701 811 -13.6%
Service · Medicaid 26 21 +23.8%
Premium Tax Revenue 6,275 3,863 +62.4%
Show Business Segments breakouts
Medicaid · Operating Segments 6,275 3,863 +62.4%
Revenue 48,742 39,836 +22.4%
Show Business Segments breakouts
All Other Segments 1,224 1,210 +1.2%
All Other Segments · Intersegment Elimination -3,967 -4,081 +2.8%
All Other Segments · Operating Segments 3,967 4,081 -2.8%
Commercial 10,070 8,535 +18.0%
Medicaid 27,998 24,113 +16.1%
Medicare 9,450 5,978 +58.1%
Show Consolidation Items breakouts
Intersegment Elimination -3,967 -4,081 +2.8%
Operating Segments 3,967 4,081 -2.8%
Policyholder Benefits And Claims Incurred Net 38,808 30,765 +26.1%
Show Business Segments breakouts
All Other Segments 516 397 +30.0%
Commercial 9,124 6,268 +45.6%
Medicaid 20,581 18,767 +9.7%
Medicare 8,587 5,333 +61.0%
Cost of Revenue 641 680 -5.7%
Show Business Segments breakouts
All Other Segments 616 658 -6.4%
Medicaid 25 22 +13.6%
Selling, General & Administrative 3,036 2,894 +4.9%
Depreciation 141 133 +6.0%
Amortization Of Intangible Assets 173 173 0.0%
Premium Tax Expense 6,346 3,962 +60.2%
Asset Impairment Charges 55 — —
Total Costs & Expenses 49,200 38,607 +27.4%
Operating Income -458 1,229 -137.3%
Investment Income Nonoperating 371 463 -19.9%
Interest Expense -170 -176 +3.4%
Income Before Taxes -257 1,516 -117.0%
Income Tax Expense (Benefit) 2 370 -99.5%
Net Income -259 1,146 -122.6%
Net Income Loss Attributable To Noncontrolling Interest 6 — —
Net Income -253 1,146 -122.1%
EPS (Basic) -0.51 2.16 -123.6%
EPS (Diluted) -0.51 2.16 -123.6%
Wtd Avg Shares (Basic) 493,548 529,602 -6.8%
Wtd Avg Shares (Diluted) 493,548 530,755 -7.0%
Gross Profit 3,018 4,528 -33.3%
Show Business Segments breakouts
All Other Segments 92 155 -40.6%
Commercial 946 2,267 -58.3%
Medicaid 1,117 1,461 -23.5%
Medicare 863 645 +33.8%
Other Non-Operating Income (Expense) 201 287 -30.0%
Comprehensive Income -147 1,130 -113.0%
Revenue From Contract With Customer Including Assessed Tax 48,742 39,836 +22.4%
Show Business Segments breakouts
All Other Segments · Operating Segments 1,224 1,210 +1.2%
Commercial · Operating Segments 10,070 8,535 +18.0%
Medicaid · Operating Segments 27,998 24,113 +16.1%
Medicare · Operating Segments 9,450 5,978 +58.1%

Balance Sheet

Balance Sheet
Metric Q2 2025 Q2 2024 YoY
Current Assets
Cash & Cash Equivalents 14,513 17,605 -17.6%
Premiums And Other Receivables Net 21,552 16,587 +29.9%
Short-Term Investments 2,768 2,609 +6.1%
Other Assets Current 1,556 1,605 -3.1%
Total Current Assets 40,389 38,406 +5.2%
Non-Current Assets
Long Term Investments 18,797 16,870 +11.4%
Other Restricted Assets Noncurrent 1,411 1,415 -0.3%
Property, Plant & Equipment 2,122 2,041 +4.0%
Goodwill 17,558 17,558 0.0%
Other Non-Current Assets 1,108 1,092 +1.5%
Total Assets 86,395 83,137 +3.9%
Other Assets
Intangible Assets Net Excluding Goodwill 5,010 5,755 -12.9%
Current Liabilities
Liability For Claims And Claims Adjustment Expense 20,117 18,173 +10.7%
Show Business Segments breakouts
All Other Segments 162 125 +29.6%
Commercial 5,123 3,897 +31.5%
Medicaid 10,442 10,472 -0.3%
Medicare 4,390 3,679 +19.3%
Accounts Payable And Accrued Liabilities Current 13,520 12,232 +10.5%
Returnof Premium Payable 2,442 1,615 +51.2%
Deferred Revenue (Current) 682 597 +14.2%
Current Portion of Long-Term Debt 25 112 -77.7%
Total Current Liabilities 36,786 32,729 +12.4%
Non-Current Liabilities
Long-Term Debt 17,552 17,516 +0.2%
Deferred Tax Liabilities 651 665 -2.1%
Other Non-Current Liabilities 3,903 4,770 -18.2%
Total Liabilities 58,892 55,680 +5.8%
Other Liabilities
Redeemable Noncontrolling Interest Equity Carrying Amount 11 16 -31.2%
Stockholders' Equity
Common Stock 1 1 0.0%
Additional Paid In Capital Common Stock 20,671 20,461 +1.0%
Accumulated Other Comprehensive Income -231 -646 +64.2%
Retained Earnings 16,406 14,352 +14.3%
Treasury Stock Common Value -9,441 -6,817 -38.5%
Total Stockholders' Equity 27,406 27,351 +0.2%
Minority Interest 86 90 -4.4%
Stockholders Equity Including Portion Attributable To Noncontrolling Interest 27,492 27,441 +0.2%
Show Equity Components breakouts
Accumulated Other Comprehensive Income -231 -646 +64.2%
Additional Paid In Capital 20,671 20,461 +1.0%
Common Stock 1 1 0.0%
Noncontrolling Interest 86 90 -4.4%
Retained Earnings 16,406 14,352 +14.3%
Treasury Stock Common -9,441 -6,817 -38.5%
Total Liabilities & Equity 86,395 83,137 +3.9%

Cash Flow Statement

Cash Flow Statement
Metric YTD Q2 2025 YTD Q2 2024 YoY
Operating Activities
Depreciation And Amortization 629 614 +2.4%
Stock-Based Compensation 94 132 -28.8%
Deferred Income Taxes -116 40 -390.0%
Gain Loss On Sale Of Business 10 -103 +109.7%
Other Non-Cash Items 16 -11 +245.5%
Increase Decrease In Premiums Receivable -1,801 -1,059 -70.1%
Increase Decrease In Other Operating Assets -543 -404 -34.4%
Increase Decrease In Health Care Insurance Liabilities 1,809 173 +945.7%
Change in Deferred Revenue 21 -118 +117.8%
Increase Decrease In Accounts Payable And Accrued Liabilities 209 -1,704 +112.3%
Change in Other Liabilities 1,857 1,838 +1.0%
Net Cash from Operations 3,295 1,719 +91.7%
Investing Activities
Capital Expenditures -343 -337 -1.8%
Payments To Acquire Investments -3,593 -3,434 -4.6%
Proceeds From Sale Maturity And Collections Of Investments 2,508 2,497 +0.4%
Net Cash from Investing -1,428 -315 -353.3%
Financing Activities
Proceeds From Issuance Of Long Term Debt 750 350 +114.3%
Repayments Of Long Term Debt -1,707 -565 -202.1%
Share Repurchases -473 -954 +50.4%
Proceeds From Issuance Of Common Stock 18 25 -28.0%
Proceeds From Payments For Other Financing Activities -12 -4 -200.0%
Net Cash from Financing -1,424 -1,148 -24.0%
Supplemental
Interest Paid 320 352 -9.1%
Income Taxes Paid 504 551 -8.5%
Other Cash Flow
Net Change in Cash 443 263 +68.4%
Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents 14,599 17,715 -17.6%
Restricted Cash And Cash Equivalents 86 110 -21.8%

Values in millions USD. Source: SEC EDGAR 10-Q filing.

This table is rendered from the same JSON returned by /api/financials.

Get API Key